Member Info for 86KB

Some people make me laugh, placing at 6p and they think its all doom with fools talking about 2p. There was another pharma company share price was 0.3 and raised at 0.2 that was a terrible raise. Know the difference. Besides they raised for a diabetes asset and not for working capital like most companies do and not for P140.

Didn't expect a placing, however it is not a bad price. Only 13.7% discount, at 6p. I have seen many other companies do huge discounts. The funds are going to be used for a different project and will give them a cashrunway until 2028. If you don't know already the diabetes market is a huge market. P140 deal is still going to be delivered they are just focusing on another one of their asset to bring more value to shareholders.

Kapiglucagon has the potential to generate significant revenues for the Company by meeting the challenging technical requirements for use in the supply of glucagon in dual-hormone artificial pancreas devices which are expected to replace the current insulin-only pump devices and the Board believes it could potentially add significant value for the Company's shareholders.

I would like to reassure shareholders that P140 remains a core value driver for ImmuPharma. We continue to make good progress in detailed discussions with a number of potential partners and remain focused on completing a value‑enhancing licensing deal in 2026.

Didn't expect a placing, however it is not a bad price. Only 13.7% discount, at 6p. I have seen many other companies do huge discounts. The funds are going to be used for a different project and will give them a cashrunway until 2028. If you don't know already the diabet

I would like to reassure shareholders that P140 remains a core value driver for ImmuPharma. We continue to make good progress in detailed discussions with a number of potential partners and remain focused on completing a value‑enhancing licensing deal in 2026."

Whilst we wait worth watching and reminding that they are in disscussions with a number of different pharmas and few top 10 Global pharmas. Discussions were going very well but was just the timing. Now that they have had another quarter for discussions I would say news is vey close. GLA.

https://youtu.be/glgh9epfOzA?si=qOKLkZTKzuK2H_T-

We would get insitutional buyers once Mcap is over £100m, so would like to see us back there again at least ahead of any news.

Not sure as I was offered 6.7 to sell at that time, currently anything over 150k to buy is NT.

Large trade for 977k has just gone through. We have exceeded Fridays volume. Going to be an interesting afternoon. GLA.

Well there is a big gap between 50p to £1.47

Nice otm, should do well from these levels.

$1 billion is about £750m, so would be looking at £1.49

I would say we are looking at $1billion+ deal, they are in a strong position with their patent and being first in class. They have been in discussions with top 10 Global pharma's, that says a lot about P140. Like I said if you don't believe sell up and move on. No point wasting your time.

We are going to see more delayed trades, over 7p to buy now.

Halfbutt I have a feeling we are going to see this go on a run this week too, lots of delayed trades have been popping up since last week. Accumulation going on imo ahead of news.

Volume starting to build here and will see both feet into 7s soon imo. Above 7.63 for a breakout. Gla.

Anyways boredom can cause people to over analyse and we shall hopefully get rewarded for our patience very soon. Those who don't believe should sell up and move on. Have a good weekend all.

Spantrout go back and read what I wrote, I said we know we will get an update soon, which is true as we are due one and then said "think" it will be this month. Saying this month are my thoughts by looking at history not because of emails.

Spantrout, Lisa is not allowed to give timings and everyone will interpret emails/messages differently so I would personally say its better to speak to the company. Anyways I wasn't going off the email I was looking at the company history and when they are likely to release updates, which says March.

Halfbutt we would all like to retire early so hopefully we get what we have been waiting for. Autoimmune disease is a hot sector and I'm sure Tim is trying to sort out the best deal for shareholders. But as always manage risk and don't have all eggs in one basket.

Spantrout they have not updated the market about their business since November and looking at rns history they usually do an update in March. So I would say we are way due an update on progress.

Halfbutt agree volume is low but yet ticking up on each buy. We know we will get a business update soon and think it will be this month, so lets see what happens in the coming weeks. It has been a long wait but we are close to news so hopefully we will get rewarded for our patience.